Christina Bergmann - Concepedia

Author

Christina Bergmann

Universitätsklinikum Erlangen ORCID

Also Known As

Ana Maria Gheorghiu, Bergmann, Christina, C Bergmann, C. Bergmann, Christina Bergmann, Hamlin, Kiley, P. Zerr

136

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

Universitätsklinikum Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg University Hospital of Zurich Heinrich Heine University Düsseldorf Düsseldorf University Hospital

About

Christina Bergmann is an author at Universitätsklinikum Erlangen specializing in fibrosis, medicine, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	709
2	Cell Biology	5	5	581
3	Engineering	1	1	43
4	Natural Sciences	1	1	122
5	Cellular Physiology	1	1	43

Christina Bergmann

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis Alfiya Akhmetshina, Katrin Palumbo, Clara Dees, Nature Communications	2012	818
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up Fabian Müller, Jule Taubmann, Laura Bucci, New England Journal of Medicine	2024	773
Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis Debomita Chakraborty, Barbora Šumová, Tatjana Mallano, Nature Communications ImmunologyImmune RegulationInflammationTranscriptional RegulationSignaling Pathway	2017	332
Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging Christian Schmidkonz, Simon Rauber, Armin Atzinger, Annals of the Rheumatic Diseases	2020	175
68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study Christina Bergmann, Jörg H. W. Distler, Christoph Treutlein, The Lancet Rheumatology FibrosisAdvanced Lung DiseaseMedicine68Ga-fapi-04 Pet-ctRisk Evaluation	2021	128
TGF-β–induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis Clara Dees, Sebastian Pötter, Yun Zhang, Journal of Clinical Investigation Tgf-β–induced Epigenetic DeregulationImmunologyDermatologyInflammationTranscriptional Regulation	2020	122
The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis Ariella Zehender, Jingang Huang, Andrea‐Hermina Györfi, Nature Communications	2018	118
CD19-CAR T-cell therapy induces deep tissue depletion of B cells Carlo Tur, Markus Eckstein, Joachim Velden, Annals of the Rheumatic Diseases	2024	110
Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway Christina Bergmann, Alfiya Akhmetshina, Clara Dees, Annals of the Rheumatic Diseases	2011	103
Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages Christiane Maier, Andreas Ramming, Christina Bergmann, Annals of the Rheumatic Diseases	2017	100

Page 1